Response to lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2 V617F mutation.

LEUKEMIA & LYMPHOMA(2010)

Cited 8|Views2
No score
Abstract
In recent years, knowledge about the role of the JAK2 V617F somatic mutation in the pathogenesis of bcr/abl negative myeloproliferative neoplasms (MPNs) has led to consideration of the mutational s...
More
Translated text
Key words
myelodysplastic syndrome,mutation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined